BTS
SGYP

BB&T Securities’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BB&T Securities’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,200
Closed -$17K – 1662
2018
Q2 		$17K Hold
10,200
– – ﹤0.01% 1531
2018
Q1 		$18K Hold
10,200
– – ﹤0.01% 1486
2017
Q4 		$22K Buy
+10,200
New +$25.4K ﹤0.01% 1433

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BB&T Securities's SGYP Position: Q3 2018 in Review

BB&T Securities sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2018, closing a stake of 10,200 shares — an estimated $17K sold.

BB&T Securities first reported a position in SGYP in Q4 2017 and held it in 3 quarters. The position peaked at $22K in Q4 2017. 133 funds tracked by Wall St. Rank hold SGYP as of Q3 2018.

  • BB&T Securities reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2018 after selling out during the quarter.
  • BB&T Securities sold 10,200 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2018, an estimated $17K.
  • BB&T Securities first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2017 and held it in 3 quarters.
  • BB&T Securities's Synergy Pharmaceuticals, Inc Common Stock position peaked at $22K in Q4 2017.
  • 133 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2018.

Based on BB&T Securities's 13F filing for Q3 2018, filed 14 Nov 2018.